All Stories

  1. Gender concordance and its association with communication and the doctor-patient relationship: a systematic review

    Article • Health Policy, August 2026, Elsevier

    Dr Roberta Gualtierotti

  2. Cord Blood-Derived Versus Homologous Donor Platelet-Rich Plasma (PRP) in Early Knee Osteoarthritis: A Single-Center, Randomized, Double-Blind Pilot Clinical Trial

    Article • Bioengineering, July 2026, MDPI AG

    Dr Roberta Gualtierotti

  3. Iron, autoimmunity, and thrombosis: Exploring sex-specific interactions

    Article • Autoimmunity Reviews, July 2026, Elsevier

    Dr Roberta Gualtierotti

  4. Thrombin Generation as a Potential Surrogate Marker of Hemostatic Status in the Era of Novel Therapies for Hemophilia

    Article • Thrombosis and Haemostasis, May 2026, Thieme Publishing Group

    Dr Roberta Gualtierotti

  5. Differential expression of miR-128 in memory T cells of patients with severe hemophilia A with and without inhibitors

    Article • Research and Practice in Thrombosis and Haemostasis, May 2026, Elsevier

    Dr Roberta Gualtierotti

  6. Diagnosis and management of hemophilia A and B

    Article • Journal of Thrombosis and Haemostasis, April 2026, Elsevier

    Dr Roberta Gualtierotti

  7. Sex Differences in Cancer-Associated Thrombosis

    Article • International Journal of Molecular Sciences, March 2026, MDPI AG

    Dr Roberta Gualtierotti

  8. Artificial Intelligence for Automated Detection of Joint Bleeding via Ultrasound in Hemophilia: Advancing Standardization

    Article • Journal of Thrombosis and Haemostasis, March 2026, Elsevier

    Dr Roberta Gualtierotti

  9. Correction to: Usefulness of Cone-Beam Computed Tomography and Automatic Vessel Detection Software in Embolization for Osteoarthritis

    Article • Cardiovascular Radiology, February 2026, Springer Science + Business Media

    Dr Roberta Gualtierotti

  10. Association of SARS-CoV-2 infection with long-lasting increase in circulating IL-32 levels

    Article • Frontiers in Immunology, February 2026, Frontiers

    Dr Roberta Gualtierotti

  11. IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation Modulation

    Article • International Journal of Molecular Sciences, January 2026, MDPI AG

    Dr Roberta Gualtierotti

  12. Platelet function abnormalities in acquired hemophilia A

    Article • Research and Practice in Thrombosis and Haemostasis, January 2026, Elsevier

    Dr Roberta Gualtierotti

  13. Involvement of the contact pathway in COVID-19 coagulopathy

    Article • Internal and Emergency Medicine, November 2025, Springer Science + Business Media

    Dr Roberta Gualtierotti

  14. Usefulness of Cone-Beam Computed Tomography and Automatic Vessel Detection Software in Embolization for Osteoarthritis

    Article • Cardiovascular Radiology, November 2025, Springer Science + Business Media

    Dr Roberta Gualtierotti

  15. Emicizumab, the factor VIII mimetic bispecific monoclonal antibody: effects on thrombin generation and thromboelastometry

    Article • Research and Practice in Thrombosis and Haemostasis, November 2025, Elsevier

    Dr Roberta Gualtierotti

  16. Measurement of cleaved high-molecular-weight kininogen in patients with hereditary angioedema due to C1-inhibitor deficiency: preanalytical and analytical optimization

    Article • Journal of Immunological Methods, November 2025, Elsevier

    Dr Roberta Gualtierotti

  17. Orthopaedic Surgery Outcomes in Patients With Haemophilia A or B Treated With Extended Half‐Life Recombinant Factor VIII and IX Fc Fusion Proteins: A Multicentre Prospective Study

    Article • Haemophilia, October 2025, Wiley

    Dr Roberta Gualtierotti

  18. A Challenging Case of Immune-Related Organizing Pneumonitis Following Programmed Cell Death 1 Inhibitor Therapy in Non-Small Cell Lung Cancer

    Article • Journal of Clinical Medicine Research, October 2025, Elmer Press, Inc.

    Dr Roberta Gualtierotti

  19. Thickening of the Intramuscular Fascia of the Iliacus Muscle as Evidence of Myofascial Pathology: A New Hip Pain Syndrome

    Article • Pain and Therapy, September 2025, Springer Science + Business Media

    Dr Roberta Gualtierotti

  20. Interactive Guidance for Self-Acquisition of Ultrasound Images by Hemophilic Patients

    Article • September 2025, ACM (Association for Computing Machinery)

    Dr Roberta Gualtierotti

  21. Multidisciplinary consensus on the diagnosis and management of patients with atypical Hemolytic Uremic Syndrome (complement-mediated TMA): Recommendations from Italian scientific societies, patient associations and regulators

    Article • Pharmacological Research, June 2025, Elsevier

    Dr Roberta Gualtierotti

  22. Bridging the gap: Time to integrate sex and gender differences into research and clinical practice for improved health outcomes

    Article • European Journal of Internal Medicine, February 2025, Elsevier

    Dr Roberta Gualtierotti

  23. Mitochondrial function in patients affected with fibromyalgia syndrome is impaired and correlates with disease severity

    Article • Scientific Reports, December 2024, Springer Science + Business Media

    Dr Roberta Gualtierotti

  24. Gene therapy in hemophilia: the dawn of a new era

    Article • Research and Practice in Thrombosis and Haemostasis, November 2024, Elsevier

    Dr Roberta Gualtierotti

  25. Exploring the Impact of Sex and Gender in Brain Function: Implications and Considerations

    Article • Advances in Therapy, October 2024, Springer Science + Business Media

    Dr Roberta Gualtierotti

  26. LoRIS - Weakly-Supervised Anomaly Detection for Ultrasound Images

    Article • October 2024, Springer Science + Business Media

    Dr Roberta Gualtierotti

  27. Fibro-adhesive Bursitis: A Novel Sonographic Finding in Adhesive Capsulitis Patients and a Proposal of Management

    Article • Rheumatology and Therapy, September 2024, Springer Science + Business Media

    Dr Roberta Gualtierotti

  28. Optimizing long-term joint health in the treatment of hemophilia

    Article • Expert Review of Hematology, September 2024, Taylor & Francis

    Francesco Poggi, Dr Roberta Gualtierotti

  29. Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life

    Article • Journal of Clinical Medicine, August 2024, MDPI AG

    Dr Roberta Gualtierotti

  30. Mitochondrial function in patients affected with fibromyalgia syndrome is impaired and correlates with disease severity

    Article • July 2024, Springer Science + Business Media

    Dr Roberta Gualtierotti

  31. Insights on the Development of PRACTICE, A Research-Oriented Healthcare Platform

    Article • June 2024, Institute of Electrical & Electronics Engineers (IEEE)

    Dr Roberta Gualtierotti

  32. International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology

    Article • Journal of Thrombosis and Haemostasis, June 2024, Elsevier

    Dr Roberta Gualtierotti

  33. Bleeding and thrombotic events and intensity of heparin therapy in the two first waves of COVID-19

    Article • Internal and Emergency Medicine, May 2024, Springer Science + Business Media

    Dr Roberta Gualtierotti

  34. Assessing joint health in haemophilia patients: The combined value of physical examination and ultrasound imaging

    Article • Haemophilia, May 2024, Wiley

    Dr Roberta Gualtierotti

  35. Gender equity in hemophilia: need for healthcare, familial, and societal advocacy

    Article • Frontiers in Medicine, April 2024, Frontiers

    Dr Roberta Gualtierotti

  36. Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis

    Article • Blood Advances, March 2024, American Society of Hematology

    Dr Roberta Gualtierotti

  37. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

    Article • Journal of Infection and Public Health, March 2024, Elsevier

    Dr Roberta Gualtierotti

  38. Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome

    Article • Haemophilia, February 2024, Wiley

    Dr Roberta Gualtierotti

  39. The value‐based healthcare approach to haemophilia: Development of outcome measures for the evaluation of care of people with haemophilia

    Article • Haemophilia, February 2024, Wiley

    Dr Roberta Gualtierotti

  40. Single-cell transcriptomic analysis to identify endomembrane regulation of metalloproteins and motor proteins in autoimmunity

    Article • January 2024, Elsevier

    Dr Roberta Gualtierotti

  41. Ultrasound evaluation of hemophilic arthropathy: a proposal of definitions in a changing landscape

    Article • Research and Practice in Thrombosis and Haemostasis, January 2024, Elsevier

    Dr Roberta Gualtierotti

  42. Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A

    Article • Blood Advances, October 2023, American Society of Hematology

    Dr Roberta Gualtierotti

  43. Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia

    Article • Journal of Clinical Medicine, October 2023, MDPI AG

    Dr Roberta Gualtierotti

  44. The role of immune suppression in COVID-19 hospitalization: clinical and epidemiological trends over three years of SARS-CoV-2 epidemic

    Article • Frontiers in Medicine, September 2023, Frontiers

    Dr Roberta Gualtierotti

  45. A second update on mapping the human genetic architecture of COVID-19

    Article • Nature, September 2023, Springer Science + Business Media

    Jose Krieger, Prof Giuseppe Bellelli, Hugh Montgomery, Dr Roberta Gualtierotti

  46. Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study

    Article • Journal of Clinical Medicine, August 2023, MDPI AG

    Dr Roberta Gualtierotti

  47. Anti-emicizumab antibodies do not cross-react with mim8 in vitro

    Article • Research and Practice in Thrombosis and Haemostasis, August 2023, Elsevier

    Dr Roberta Gualtierotti

  48. Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy.

    Article • Blood Advances, July 2023, American Society of Hematology

    Dr Roberta Gualtierotti

  49. Exploring the prevalence and clinical impact of fibromyalgia syndrome in patients with shoulder diseases: a cross-sectional study

    Article • Clinical and Experimental Rheumatology, June 2023, Clinical and Experimental Rheumatology

    Dr Roberta Gualtierotti

  50. Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 Patients

    Article • Journal of Clinical Medicine, May 2023, MDPI AG

    Dr Roberta Gualtierotti

  51. Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients

    Article • Haematologica, March 2023, Ferrata Storti Foundation (Haematologica)

    Dr Roberta Gualtierotti

  52. Ultrasound detection of subquadricipital recess distension

    Article • Intelligent Systems with Applications, February 2023, Elsevier

    Dr Roberta Gualtierotti

  53. Editorial: The molecular mechanisms and therapeutic targets of atherosclerosis

    Article • Frontiers in Cardiovascular Medicine, January 2023, Frontiers

    Dr Massimiliano Ruscica, Dr Roberta Gualtierotti

  54. GAJA - Guided self-Acquisition of Joint ultrAsound images

    Article • January 2023, Springer Science + Business Media

    Dr Roberta Gualtierotti

  55. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations

    Article • Frontiers in Immunology, December 2022, Frontiers

    Dr Roberta Gualtierotti

  56. Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination

    Article • Blood Advances, October 2022, American Society of Hematology

    Dr Roberta Gualtierotti

  57. Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis

    Article • Frontiers in Cardiovascular Medicine, October 2022, Frontiers

    Dr Roberta Gualtierotti

  58. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations

    Article • September 2022, openRxiv

    Dr Roberta Gualtierotti

  59. Updates on Novel Non-Replacement Drugs for Hemophilia

    Article • Pharmaceuticals, September 2022, MDPI AG

    Dr Roberta Gualtierotti

  60. Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit

    Article • Journal of Clinical Medicine, September 2022, MDPI AG

    Dr Roberta Gualtierotti

  61. Are IF-ANA the guiding light for SLE classification in the real-world setting?

    Article • Autoimmunity Reviews, September 2022, Elsevier

    Dr Roberta Gualtierotti

  62. Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study

    Article • Internal and Emergency Medicine, August 2022, Springer Science + Business Media

    Dr Roberta Gualtierotti

  63. Successful Chemical Synovectomy in a Patient with Acquired von Willebrand Syndrome with Chronic Synovitis Due to Recurrent Knee Hemarthrosis: A Case Report

    Article • Rheumatology and Therapy, August 2022, Springer Science + Business Media

    Dr Roberta Gualtierotti

  64. External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019

    Article • European Journal of Internal Medicine, August 2022, Elsevier

    Dr Roberta Gualtierotti

  65. The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy

    Article • PLOS One, July 2022, PLOS

    Dr Roberta Gualtierotti

  66. Real‐world data on emicizumab prophylaxis in the Milan cohort

    Article • Haemophilia, July 2022, Wiley

    Dr Roberta Gualtierotti

  67. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Article • Human Molecular Genetics, July 2022, Oxford University Press (OUP)

    Lise Tuset Gustad, Prof Giuseppe Bellelli, Dr Roberta Gualtierotti

  68. Play4Physio: Supporting Physical Therapy of Children with Hemophilia

    Article • June 2022, ACM (Association for Computing Machinery)

    Dr Roberta Gualtierotti, Dragan Ahmetovic

  69. Plasma Exchange in a Patient with Immune Thrombocytopenia Associated with Antiphospholipid Syndrome Hospitalized for COVID-19

    Article • Rheumatology and Therapy, June 2022, Springer Science + Business Media

    Dr Roberta Gualtierotti

  70. A Response to: Letter to the Editor Regarding Ultrasound Features of Adhesive Capsulitis

    Article • Rheumatology and Therapy, May 2022, Springer Science + Business Media

    Dr Roberta Gualtierotti

  71. External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019

    Article • March 2022, openRxiv

    Dr Roberta Gualtierotti

  72. Genetic variants at the chromosomal region 2q21.3 underlying inhibitor development in patients with severe haemophilia A

    Article • Haemophilia, February 2022, Wiley

    Dr Roberta Gualtierotti

  73. Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients

    Article • European Journal of Clinical Investigation, February 2022, Wiley

    Dr Roberta Gualtierotti

  74. The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy

    Article • February 2022, openRxiv

    Dr Roberta Gualtierotti

  75. Current and Emerging Approaches for Pain Management in Hemophilic Arthropathy

    Article • Pain and Therapy, January 2022, Springer Science + Business Media

    Dr Roberta Gualtierotti

  76. Ultrasound Features of Adhesive Capsulitis

    Article • Rheumatology and Therapy, December 2021, Springer Science + Business Media

    Dr Roberta Gualtierotti

  77. Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy

    Article • Frontiers in Cellular Neuroscience, November 2021, Frontiers

    Dr Roberta Gualtierotti

  78. Rehabilitation through Accessible Mobile Gaming and Wearable Sensors

    Article • October 2021, ACM (Association for Computing Machinery)

    Dr Roberta Gualtierotti

  79. Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment

    Article • Internal and Emergency Medicine, August 2021, Springer Science + Business Media

    Dr Roberta Gualtierotti

  80. Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment

    Article • Internal and Emergency Medicine, August 2021, Springer Science + Business Media

    Dr Roberta Gualtierotti

  81. No changes of parameters nor coagulation activation in healthy subjects vaccinated for SARS-Cov-2

    Article • Thrombosis Update, August 2021, Elsevier

    Dr Roberta Gualtierotti

  82. Hemophilic arthropathy: Current knowledge and future perspectives

    Article • Journal of Thrombosis and Haemostasis, July 2021, Wiley

    Dr Roberta Gualtierotti

  83. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Article • July 2021, Cold Spring Harbor Laboratory Press

    Lise Tuset Gustad, Prof Giuseppe Bellelli, Dr Roberta Gualtierotti

  84. Mapping the human genetic architecture of COVID-19

    Article • Nature, July 2021, Springer Science + Business Media

    Michael Olanipekun, Professor Ahilanandan Dushianthan, Roberta Russo, MD Massimo Girardis, Hugh Montgomery, Dr Hong Bin Kim, Lise Tuset Gustad, JUNICHI SASAKI, Dr Roberta Gualtierotti

  85. Disease-modifying anti-rheumatic drugs (DMARDs) for Sjogren’s syndrome

    Article • Cochrane Database of Systematic Reviews, May 2021, Wiley

    Dr Roberta Gualtierotti

  86. Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment: An Observational Study Showing that Things Are Not Always as They Seem

    Article • Advances in Therapy, April 2021, Springer Science + Business Media

    Dr Roberta Gualtierotti

  87. The ADAMTS13‐von Willebrand factor axis in COVID‐19 patients

    Article • Journal of Thrombosis and Haemostasis, February 2021, Elsevier

    Dr Roberta Gualtierotti

  88. Complement activation and endothelial perturbation parallel COVID-19 severity and activity

    Article • Journal of Autoimmunity, January 2021, Elsevier

    Claudia Grossi, Dr Roberta Gualtierotti

  89. Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes

    Article • Frontiers in Immunology, December 2020, Frontiers

    Dr Roberta Gualtierotti

  90. COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia

    Article • Clinical Microbiology and Infection, November 2020, Elsevier

    Dr Roberta Gualtierotti

  91. The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians

    Article • Journal of Clinical Medicine, October 2020, MDPI AG

    Dr Roberta Gualtierotti

  92. Genomewide Association Study of Severe Covid-19 with Respiratory Failure

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 2020, New England Journal of Medicine (NEJM/MMS)

    Dr Roberta Gualtierotti

  93. Hemostatic alterations in COVID-19

    Article • Haematologica, August 2020, Ferrata Storti Foundation (Haematologica)

    Dr Roberta Gualtierotti

  94. Inflammatory interactions between degenerated intervertebral discs and microglia: implication of sphingosine‐1‐phosphate signalling

    Article • Journal of Orthopaedic Research®, August 2020, Wiley

    Dr Roberta Gualtierotti

  95. Management of Painful Shoulder Arthroplasty: A Narrative Review

    Article • Pain and Therapy, July 2020, Springer Science + Business Media

    Dr Roberta Gualtierotti

  96. Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study

    Article • Journal of Clinical Medicine, July 2020, MDPI AG

    Dr Roberta Gualtierotti

  97. Complement activation in patients with COVID-19: A novel therapeutic target

    Article • Journal of Allergy and Clinical Immunology, July 2020, Elsevier

    Dr Roberta Gualtierotti

  98. The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis

    Article • June 2020, openRxiv

    Dr Roberta Gualtierotti

  99. Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report

    Article • The American Journal of Gastroenterology, May 2020, Wolters Kluwer Health

    Dr Roberta Gualtierotti

  100. Early phases of COVID-19 are characterized by a reduction of lymphocyte populations and the presence of atypical monocytes

    Article • May 2020, openRxiv

    Dr Roberta Gualtierotti

  101. Evidence for a pathogenic role of extrafollicular, IL-10–producing CCR6 + B helper T cells in systemic lupus erythematosus

    Article • Proceedings of the National Academy of Sciences, March 2020, Proceedings of the National Academy of Sciences

    Dr Roberta Gualtierotti

  102. Hereditary Deficiency of the Second Component of Complement: Early Diagnosis and 21-Year Follow-Up of a Family

    Article • Medicina, March 2020, MDPI AG

    Dr Roberta Gualtierotti

  103. IFI16 and Anti-IFI16 as Novel Biomarkers for Sjoegren’s Syndrome: Preliminary Data

    Article • Proceedings, December 2019, MDPI AG

    Dr Roberta Gualtierotti, Professor Marco De Andrea

  104. Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis

    Article • Advances in Therapy, October 2019, Springer Science + Business Media

    Dr Roberta Gualtierotti

  105. Fibromyalgia and Shoulder Surgery: A Systematic Review and a Critical Appraisal of the Literature

    Article • Journal of Clinical Medicine, September 2019, MDPI AG

    Dr Roberta Gualtierotti

  106. Identification of a Shared Microbiomic and Metabolomic Profile in Systemic Autoimmune Diseases

    Article • Journal of Clinical Medicine, August 2019, MDPI AG

    Dr Roberta Gualtierotti

  107. Efficacy and Metabolic Effect on Serum Lipids of Apremilast in Psoriatic Arthritis: A Case Report

    Article • Journal of Clinical Medicine, March 2019, MDPI AG

    Dr Roberta Gualtierotti

  108. P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus

    Article • Journal of Experimental Medicine, January 2019, Rockefeller University Press

    Dr Roberta Gualtierotti

  109. Vitamin D and Anti-Phospholipid Antibody Syndrome: A Comprehensive Review

    Article • The Open Rheumatology Journal, December 2018, Bentham Science Publishers

    Dr Roberta Gualtierotti

  110. Main Oral Manifestations in Immune-Mediated and Inflammatory Rheumatic Diseases

    Article • Journal of Clinical Medicine, December 2018, MDPI AG

    Dr Roberta Gualtierotti

  111. Total Joint Arthroplasty in Patients with Inflammatory Rheumatic Diseases

    Article • Advances in Therapy, July 2018, Springer Science + Business Media

    Dr Roberta Gualtierotti

  112. The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts

    Article • Medicine, April 2018, Wolters Kluwer Health

    Dr Roberta Gualtierotti

  113. Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview

    Article • Advances in Therapy, March 2018, Springer Science + Business Media

    Dr Roberta Gualtierotti

  114. Detection of early endothelial damage in patients with Raynaud's phenomenon

    Article • Microvascular Research, September 2017, Elsevier

    Dr Roberta Gualtierotti

  115. Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis

    Article • Rheumatology and Therapy, July 2017, Springer Science + Business Media

    Dr Roberta Gualtierotti

  116. Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review

    Article • Clinical Reviews in Allergy & Immunology, July 2017, Springer Science + Business Media

    Dr Roberta Gualtierotti

  117. Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids

    Article • Advances in Therapy, January 2017, Springer Science + Business Media

    Dr Roberta Gualtierotti

  118. Understanding cardiovascular risk in rheumatoid arthritis: Still a long way to go

    Article • Atherosclerosis, January 2017, Elsevier

    Dr Roberta Gualtierotti

  119. Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis

    Article • Swiss Medical Weekly, December 2016, EMH Swiss Medical Publishers, Ltd.

    Dr Roberta Gualtierotti

  120. Health-Related Quality of Life in Systemic Sclerosis: Feasibility and Construct Validity of Eq-5d

    Article • Value in Health, November 2016, Elsevier

    Dr Roberta Gualtierotti

  121. The Adipose Mesenchymal Stem Cell Secretome Inhibits Inflammatory Responses of Microglia: Evidence for an Involvement of Sphingosine-1-Phosphate Signalling

    Article • Stem Cells and Development, July 2016, Mary Ann Liebert Inc

    Dr Roberta Gualtierotti

  122. Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes

    Article • Mediators of Inflammation, January 2016, Hindawi Publishing Corporation

    Dr Roberta Gualtierotti

  123. A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study

    Article • Microvascular Research, November 2015, Elsevier

    Dr Roberta Gualtierotti

  124. Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds

    Article • Organogenesis, October 2015, Taylor & Francis

    Dr Roberta Gualtierotti

  125. Corrigendum to ‘Autoantibodies to coagulation factors: From pathophysiology to diagnosis and therapy’ [Autoimmun Rev 13/1 (2014) p.40–48]

    Article • Autoimmunity Reviews, July 2015, Elsevier

    Dr Roberta Gualtierotti

  126. AB1085 Empirical Approach to Investigate Raynaud's Phenomenon: The Pearl Study

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    Dr Roberta Gualtierotti, Claudia Grossi

  127. OP0221 Nailfold Capillaroscopy Patterns in Adulthood are Similar in Patients with Juvenile and Adult-Onset Systemic Sclerosis: A Eustar Case-Control Study

    Article • Annals of the Rheumatic Diseases, June 2015, BMJ

    Dr Roberta Gualtierotti

  128. Sparing effect of hemiplegia on skin fibrosis and microvascular involvement: Reports of two cases of systemic sclerosis and review of the literature

    Article • Seminars in Arthritis and Rheumatism, April 2015, Elsevier

    Dr Roberta Gualtierotti

  129. Gene Expression Profile Analysis of Human Mesenchymal Stem Cells from Herniated and Degenerated Intervertebral Discs Reveals Different Expression of Osteopontin

    Article • Stem Cells and Development, February 2015, Mary Ann Liebert Inc

    Dr Roberta Gualtierotti

  130. Choroidal impairment and macular thinning in patients with systemic sclerosis: The acute study

    Article • Microvascular Research, January 2015, Elsevier

    Dr Roberta Gualtierotti

  131. Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud’s Phenomenon

    Article • Journal of Immunology Research, January 2015, Hindawi Publishing Corporation

    Dr Roberta Gualtierotti

  132. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome

    Article • Journal of Thrombosis and Haemostasis, September 2014, Elsevier

    Massimo Cugno, Dr Roberta Gualtierotti

  133. AB1013 Systemic Sclerosis and Myositis Extractable Nuclear Antigen (ENA) Analysis: Profile of A Cohort of Subjects with Isolated Raynaud's Phenomenon

    Article • Annals of the Rheumatic Diseases, June 2014, BMJ

    Dr Roberta Gualtierotti, Claudia Grossi

  134. Authors’ Reply to Verdelli et al.: There Is No Knowledge Without Experience

    Article • Clinical Drug Investigation, May 2014, Springer Science + Business Media

    Dr Roberta Gualtierotti

  135. Focus on the potential effects of treatments for spondylarthritides on cardiovascular risk

    Article • Expert Review of Clinical Immunology, January 2014, Taylor & Francis

    Dr Roberta Gualtierotti

  136. Autoantibodies to coagulation factors: From pathophysiology to diagnosis and therapy

    Article • Autoimmunity Reviews, January 2014, Elsevier

    Dr Roberta Gualtierotti

  137. Rheumatoid Factors

    Article • January 2014, Elsevier

    Dr Roberta Gualtierotti

  138. Fibrosis biomarkers in isolated Raynaud's phenomenon: too little, too soon?

    Article • Annals of the Rheumatic Diseases, December 2013, BMJ

    Dr Roberta Gualtierotti, Claudia Grossi

  139. Choosing treatment options for patients with relapsed/refractory multiple myeloma

    Article • Expert Review of Anticancer Therapy, December 2013, Taylor & Francis

    Dr Roberta Gualtierotti

  140. Is it safe to withdraw etanercept in established rheumatoid arthritis after low disease activity achievement?

    Article • Internal and Emergency Medicine, December 2013, Springer Science + Business Media

    Dr Roberta Gualtierotti

  141. Tocilizumab Monotherapy in a Patient with Rheumatoid Arthritis and Iatrogenic Kaposi Sarcoma

    Article • Clinical Drug Investigation, December 2013, Springer Science + Business Media

    Dr Roberta Gualtierotti

  142. Effect of imidapril versus ramipril on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuria

    Article • Expert Opinion on Pharmacotherapy, November 2013, Informa Healthcare

    Dr Roberta Gualtierotti

  143. A systematic overview on the use and relevance of capillaroscopy in systemic sclerosis

    Article • Expert Review of Clinical Immunology, November 2013, Taylor & Francis

    Dr Roberta Gualtierotti

  144. Nailfold capillary patterns in healthy subjects: A real issue in capillaroscopy

    Article • Microvascular Research, November 2013, Elsevier

    Dr Roberta Gualtierotti

  145. Effect of naproxen and acetaminophen on blood pressure lowering by ramipril, valsartan and aliskiren in hypertensive patients

    Article • Expert Opinion on Pharmacotherapy, July 2013, Informa Healthcare

    Dr Roberta Gualtierotti

  146. SAT0214 Reliability and Validity of the Italian Version of the Ucla-Scleroderma Clinical Trial Consortium-Gastrointestinal Tract Instrument in Patients with Systemic Sclerosis

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Andrea Becciolini, Dr Roberta Gualtierotti

  147. AB0830 Role of anti-IFI16 antibodies and NT-PROBNP as candidate biomarkers in systemic sclerosis

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr Roberta Gualtierotti

  148. FRI0402 Vascular changes in choroid plexus in patients with raynaud’s phenomenon suspected secondary to a connective tissue disease

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr Roberta Gualtierotti

  149. FRI0403 How early starts increased collagen synthesis in systemic sclerosis?

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr Roberta Gualtierotti

  150. SAT0401 The nailfold capillary patterns in healthy subjects: A two center study

    Article • Annals of the Rheumatic Diseases, June 2013, BMJ

    Dr Roberta Gualtierotti

  151. Pre-conceptional exposure to rituximab: comment on the article by Ojeda-Uribe et al.

    Article • Clinical Rheumatology, May 2013, Springer Science + Business Media

    Dr Roberta Gualtierotti

  152. An overlooked cause of back pain and stiffness

    Article • Rheumatology, January 2013, Oxford University Press (OUP)

    Dr Roberta Gualtierotti

  153. Current and Emerging Treatment Options for Patients with Relapsed Myeloma

    Article • Clinical Medicine Insights Oncology, January 2013, SAGE Publications

    Dr Roberta Gualtierotti

  154. Rheumatoid Factors: Clinical Applications

    Article • Disease Markers, January 2013, Hindawi Publishing Corporation

    Dr Roberta Gualtierotti

  155. Rheumatoid Nodules Predating Seroconversion and Rheumatoid Arthritis: An Uncommon Case Report

    Article • Journal of Clinical & Cellular Immunology, January 2013, OMICS Publishing Group

    Dr Roberta Gualtierotti

  156. The Role of Ultrasonography in the Assessment of Skeletal Hand Involvement in Systemic Sclerosis

    Article • Journal of Medical Ultrasound, December 2011, Medknow

    Dr Roberta Gualtierotti

  157. Nailfold capillaroscopic report: qualitative and quantitative methods

    Article • Reumatismo, September 2011, PAGEPress Publications

    Dr Roberta Gualtierotti

  158. Health related quality of life assessment in patients with systemic sclerosis

    Article • Reumatismo, June 2011, PAGEPress Publications

    Dr Roberta Gualtierotti

  159. Cutting-Edge Issues in Coronary Disease and the Primary Antiphospholipid Syndrome

    Article • Clinical Reviews in Allergy & Immunology, March 2011, Springer Science + Business Media

    Dr Roberta Gualtierotti

  160. Updating on the pathogenesis of systemic lupus erythematosus

    Article • Autoimmunity Reviews, November 2010, Elsevier

    Dr Roberta Gualtierotti

  161. Hand impairment in systemic sclerosis: association of different hand indices with organ involvement

    Article • Scandinavian Journal of Rheumatology, May 2010, Taylor & Francis

    Dr Roberta Gualtierotti

  162. Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis

    Article • Current Vascular Pharmacology, March 2010, Bentham Science Publishers

    Dr Roberta Gualtierotti

  163. Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy

    Article • Rheumatology, January 2010, Oxford University Press (OUP)

    Dr Roberta Gualtierotti

  164. Feasibility of Different Capillaroscopic Measures for Identifying Nailfold Microvascular Alterations

    Article • Seminars in Arthritis and Rheumatism, February 2009, Elsevier

    Dr Roberta Gualtierotti

  165. Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (Prognostic Index for Nailfold Capillaroscopic Examination)

    Article • Arthritis & Rheumatism, July 2008, Wiley

    Dr Roberta Gualtierotti

  166. Reliability and validity of the Italian version of the hand functional disability scale in patients with systemic sclerosis

    Article • Clinical Rheumatology, November 2007, Springer Science + Business Media

    Dr Roberta Gualtierotti